Editorial: Research challenges of drug utilization, data collection, data validation, and adverse drug reactions in neonates.
作者信息
Ward Robert M
机构信息
Department of Pediatrics, University of Utah, Salt Lake City, UT, United States.
出版信息
Front Pharmacol. 2024 Mar 12;15:1376770. doi: 10.3389/fphar.2024.1376770. eCollection 2024.
Abstract
摘要
相似文献
1
Editorial: Research challenges of drug utilization, data collection, data validation, and adverse drug reactions in neonates.社论：新生儿药物利用、数据收集、数据验证及药物不良反应的研究挑战
Front Pharmacol. 2024 Mar 12;15:1376770. doi: 10.3389/fphar.2024.1376770. eCollection 2024.
2
Probiotics for the Prevention of Pediatric Antibiotic-Associated Diarrhea.益生菌预防儿童抗生素相关性腹泻
Explore (NY). 2016 Nov-Dec;12(6):463-466. doi: 10.1016/j.explore.2016.08.015. Epub 2016 Aug 26.
3
Probiotics for the prevention of pediatric antibiotic-associated diarrhea.益生菌预防儿童抗生素相关性腹泻
Cochrane Database Syst Rev. 2015 Dec 22(12):CD004827. doi: 10.1002/14651858.CD004827.pub4.
4
A Computer Prescribing Order Entry-Clinical Decision Support system designed for neonatal care: results of the 'preselected prescription' concept at the bedside.一种专为新生儿护理设计的计算机处方录入-临床决策支持系统：床边“预选处方”概念的结果。
J Clin Pharm Ther. 2017 Feb;42(1):64-68. doi: 10.1111/jcpt.12474. Epub 2016 Nov 23.
5
Probiotics for the prevention of pediatric antibiotic-associated diarrhea.益生菌预防儿童抗生素相关性腹泻
Cochrane Database Syst Rev. 2007 Apr 18(2):CD004827. doi: 10.1002/14651858.CD004827.pub2.
6
Probiotics for the prevention of pediatric antibiotic-associated diarrhea.益生菌预防儿童抗生素相关性腹泻
Cochrane Database Syst Rev. 2011 Nov 9(11):CD004827. doi: 10.1002/14651858.CD004827.pub3.
7
Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.用于预防成人和儿童艰难梭菌相关性腹泻的益生菌
Cochrane Database Syst Rev. 2017 Dec 19;12(12):CD006095. doi: 10.1002/14651858.CD006095.pub4.
8
Interventions for preventing ophthalmia neonatorum.预防新生儿眼炎的干预措施。
Cochrane Database Syst Rev. 2020 Sep 21;9(9):CD001862. doi: 10.1002/14651858.CD001862.pub4.
9
Newborn hearing screening: effectiveness, importance of high-risk factors, and characteristics of infants in the neonatal intensive care unit and well-baby nursery.新生儿听力筛查：有效性、高危因素的重要性以及新生儿重症监护病房和健康婴儿护理室中婴儿的特征
Otol Neurotol. 2005 Nov;26(6):1186-90. doi: 10.1097/01.mao.0000184602.94677.41.
10
Financial impact of medication reviews by clinical pharmacists to reduce in-hospital adverse drug events: a return-on-investment analysis.临床药师进行药物审查以减少院内药物不良事件的财务影响：投资回报分析。
Int J Clin Pharm. 2024 Apr;46(2):496-505. doi: 10.1007/s11096-023-01683-w. Epub 2024 Feb 5.
本文引用的文献
1
Development of a neonatal adverse event severity scale through a Delphi consensus approach.通过德尔菲共识方法制定新生儿不良事件严重程度量表。
Arch Dis Child. 2019 Dec;104(12):1167-1173. doi: 10.1136/archdischild-2019-317399. Epub 2019 Sep 19.
2
Safety, dosing, and pharmaceutical quality for studies that evaluate medicinal products (including biological products) in neonates.评估新生儿药品（包括生物制品）的研究中的安全性、剂量和药品质量。
Pediatr Res. 2017 May;81(5):692-711. doi: 10.1038/pr.2016.221. Epub 2016 Nov 3.
3
Drug labeling and exposure in neonates.新生儿的药物标签和暴露情况。
JAMA Pediatr. 2014 Feb;168(2):130-6. doi: 10.1001/jamapediatrics.2013.4208.
Zotero 插件